AI Science Tracker
EN

An explainable machine learning-based phenomapping strategy for adaptive predictive enrichment in randomized clinical trials

Affiliation not stated in the reviewed material · 25 Nov 2023 · medicine

Discovery

An explainable machine learning-based phenomapping strategy for adaptive predictive enrichment in randomized clinical trials

Source check: Source checked. Not independent scientific confirmation.

Finding: The primary publisher Methods/Results support the AI-enabled result: Simulated group-sequential analyses of IRIS and SPRINT trials show ML phenomapping can enrich adaptive enrolment, with trial-specific evaluation. This record is limited to the study result and does not establish independent replication or real-world benefit.

Technology: Machine-learning phenomapping

Publication: Peer-reviewed paper · Test context: retrospective or benchmark. Catalog categories, not an evidence grade.

AI contribution
Simulated group-sequential analyses of IRIS and SPRINT trials show ML phenomapping can enrich adaptive enrolment, with trial-specific evaluation.
Test and result
The primary publisher Methods/Results support the AI-enabled result: Simulated group-sequential analyses of IRIS and SPRINT trials show ML phenomapping can enrich adaptive enrolment, with trial-specific evaluation.
Limitation / still unknown
The source-checked evidence does not establish broader external validity or prospective benefit. Affiliation was not available in the retrieved trusted primary metadata. Organization affiliation was not stated in the source material reviewed. Affiliation was not stated in the reviewed material.
Evidence sources and annotation context

Evidence context (descriptions follow the cited sources; test type is a catalog classification):

Evidence sources: https://www.nature.com/articles/s41746-023-00963-z

Source checked · editorial details

The source page was checked against this entry. Independent confirmation is not assessed by this label.

Source type: paper. Paper: not linked in this catalog; this does not mean no paper exists.

Review date: 22 Nov 2026. Review scope: Primary result-bearing material for the stated method, result and evaluation, with bibliographic version information..

No follow-up recorded; this is not a claim that no follow-up exists. Follow-up review scope and date are not recorded. No source-supported relationships recorded.

Editorial assessment: Impact 3/5 · Validation 2/5 · Novelty 3/5. Impact and novelty are editorial judgments; validation follows the annotated test type where one exists. Not an evidence grade. Scoring criteria.

Open in the full catalog for filters, charts and related discoveries. Browse medicine discoveries.

Related catalog entries

Links use documented relationships where available, plus shared catalog context. A shared topic or model family does not establish a scientific dependency.